| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | beta-adrenergic receptor kinase activity | 5.67e-05 | 4 | 62 | 2 | GO:0047696 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 5.67e-05 | 4 | 62 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor kinase activity | 1.97e-04 | 7 | 62 | 2 | GO:0004703 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 4.51e-04 | 446 | 62 | 7 | GO:0004674 | |
| GeneOntologyMolecularFunction | kinase activity | 5.52e-04 | 764 | 62 | 9 | GO:0016301 | |
| MousePheno | increased urine bicarbonate level | 2.64e-05 | 3 | 42 | 2 | MP:0011462 | |
| MousePheno | abnormal urine bicarbonate level | 2.64e-05 | 3 | 42 | 2 | MP:0011461 | |
| Domain | GPCR_kinase | 2.48e-04 | 7 | 65 | 2 | IPR000239 | |
| Domain | AGC-kinase_C | 9.78e-04 | 56 | 65 | 3 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 9.78e-04 | 56 | 65 | 3 | PS51285 | |
| Domain | S_TK_X | 9.78e-04 | 56 | 65 | 3 | SM00133 | |
| Domain | VitD_rcpt | 1.06e-03 | 14 | 65 | 2 | IPR000324 | |
| Domain | ARM-type_fold | 1.15e-03 | 339 | 65 | 6 | IPR016024 | |
| Domain | Ser/Thr_kinase_AS | 1.50e-03 | 357 | 65 | 6 | IPR008271 | |
| Domain | S_TKc | 1.54e-03 | 359 | 65 | 6 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 1.60e-03 | 362 | 65 | 6 | PS00108 | |
| Domain | Iontro_rcpt | 1.76e-03 | 18 | 65 | 2 | IPR001320 | |
| Domain | Lig_chan-Glu_bd | 1.76e-03 | 18 | 65 | 2 | PF10613 | |
| Domain | Iono_rcpt_met | 1.76e-03 | 18 | 65 | 2 | IPR001508 | |
| Domain | Glu/Gly-bd | 1.76e-03 | 18 | 65 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.76e-03 | 18 | 65 | 2 | SM00918 | |
| Domain | Lig_chan | 1.76e-03 | 18 | 65 | 2 | PF00060 | |
| Domain | PBPe | 1.76e-03 | 18 | 65 | 2 | SM00079 | |
| Domain | Protein_kinase_ATP_BS | 2.02e-03 | 379 | 65 | 6 | IPR017441 | |
| Domain | Pkinase | 2.08e-03 | 381 | 65 | 6 | PF00069 | |
| Domain | Kinase-like_dom | 2.71e-03 | 542 | 65 | 7 | IPR011009 | |
| Domain | TUDOR | 3.96e-03 | 27 | 65 | 2 | SM00333 | |
| Domain | Tudor | 4.87e-03 | 30 | 65 | 2 | IPR002999 | |
| Domain | PROTEIN_KINASE_ATP | 5.18e-03 | 459 | 65 | 6 | PS00107 | |
| Domain | RGS | 6.59e-03 | 35 | 65 | 2 | PF00615 | |
| Domain | RGS | 6.59e-03 | 35 | 65 | 2 | SM00315 | |
| Domain | RGS | 6.96e-03 | 36 | 65 | 2 | PS50132 | |
| Domain | Prot_kinase_dom | 7.00e-03 | 489 | 65 | 6 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 7.28e-03 | 493 | 65 | 6 | PS50011 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 4.82e-06 | 35 | 46 | 4 | MM15109 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.15e-05 | 21 | 46 | 3 | M838 | |
| Pathway | REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION | 4.79e-05 | 22 | 46 | 3 | MM15104 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.12e-04 | 29 | 46 | 3 | MM15028 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.37e-04 | 31 | 46 | 3 | M7223 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 2.44e-04 | 94 | 46 | 4 | M2843 | |
| Pathway | WP_EFFECTS_OF_NITRIC_OXIDE | 2.88e-04 | 8 | 46 | 2 | M39677 | |
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 10698974 | ||
| Pubmed | 3.20e-06 | 15 | 68 | 3 | 9481670 | ||
| Pubmed | A novel nuclear receptor heterodimerization pathway mediated by orphan receptors TR2 and TR4. | 3.77e-06 | 2 | 68 | 2 | 9737983 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8638670 | ||
| Pubmed | Kinetic properties of human AMPA-type glutamate receptors expressed in HEK293 cells. | 3.77e-06 | 2 | 68 | 2 | 12670305 | |
| Pubmed | Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. | 3.77e-06 | 2 | 68 | 2 | 7992055 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 33060647 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19131575 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22042865 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 8035170 | ||
| Pubmed | Elimination of redundant synaptic inputs in the absence of synaptic strengthening. | 3.77e-06 | 2 | 68 | 2 | 22090494 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 9694834 | ||
| Pubmed | Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily. | 3.77e-06 | 2 | 68 | 2 | 12361719 | |
| Pubmed | Embryonic and fetal beta-globin gene repression by the orphan nuclear receptors, TR2 and TR4. | 3.77e-06 | 2 | 68 | 2 | 17431400 | |
| Pubmed | Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4. | 3.77e-06 | 2 | 68 | 2 | 18316356 | |
| Pubmed | Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3. | 3.77e-06 | 2 | 68 | 2 | 10198406 | |
| Pubmed | G-protein coupled receptor kinase 2 and 3 expression in human detrusor cultured smooth muscle cells. | 3.77e-06 | 2 | 68 | 2 | 11762794 | |
| Pubmed | GluA4 is indispensable for driving fast neurotransmission across a high-fidelity central synapse. | 3.77e-06 | 2 | 68 | 2 | 21690196 | |
| Pubmed | Motor protein-dependent transport of AMPA receptors into spines during long-term potentiation. | 5.71e-06 | 18 | 68 | 3 | 18311135 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10754297 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12615366 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 28397107 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 10085131 | ||
| Pubmed | Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. | 1.13e-05 | 3 | 68 | 2 | 7761854 | |
| Pubmed | The N-termini of GRK2 and GRK3 simulate the stimulating effects of RKIP on β-adrenoceptors. | 1.13e-05 | 3 | 68 | 2 | 31604529 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12702765 | ||
| Pubmed | The TR2 and TR4 orphan nuclear receptors repress Gata1 transcription. | 1.13e-05 | 3 | 68 | 2 | 17974920 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 18163426 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12172541 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12130708 | ||
| Pubmed | An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer. | 1.13e-05 | 3 | 68 | 2 | 12093744 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 12456365 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 19217372 | ||
| Pubmed | Hypercapnic duty cycle is an intermediate physiological phenotype linked to mouse chromosome 5. | 1.13e-05 | 3 | 68 | 2 | 12794091 | |
| Pubmed | 1.78e-05 | 418 | 68 | 7 | 34709266 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 10688364 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 28608780 | ||
| Pubmed | AMPA receptor subunits expressed by single astrocytes in the juvenile mouse hippocampus. | 2.25e-05 | 4 | 68 | 2 | 9221927 | |
| Pubmed | Interaction proteomics reveals brain region-specific AMPA receptor complexes. | 2.25e-05 | 4 | 68 | 2 | 25337787 | |
| Pubmed | Auditory sensitivity regulation via rapid changes in expression of surface AMPA receptors. | 2.25e-05 | 4 | 68 | 2 | 17828255 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 21784156 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 24652293 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 17409242 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 25561507 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 14561864 | ||
| Pubmed | Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. | 2.25e-05 | 4 | 68 | 2 | 10027300 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 1319477 | ||
| Pubmed | Characterization of phosphorylation sites on the glutamate receptor 4 subunit of the AMPA receptors. | 2.25e-05 | 4 | 68 | 2 | 10366608 | |
| Pubmed | AMPA receptors regulate dynamic equilibrium of presynaptic terminals in mature hippocampal networks. | 2.25e-05 | 4 | 68 | 2 | 12692557 | |
| Pubmed | Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. | 2.25e-05 | 4 | 68 | 2 | 8917529 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 12125045 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 8662816 | ||
| Pubmed | Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus. | 2.25e-05 | 4 | 68 | 2 | 23734232 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 25433904 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 9648857 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 2.45e-05 | 608 | 68 | 8 | 36089195 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 29163060 | ||
| Pubmed | RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. | 3.75e-05 | 5 | 68 | 2 | 1717158 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 10338466 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 16129400 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 9482932 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 15797551 | ||
| Pubmed | Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. | 3.75e-05 | 5 | 68 | 2 | 28842570 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 9826657 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 19235728 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 20074556 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 12163475 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 36451830 | ||
| Pubmed | 5.74e-05 | 38 | 68 | 3 | 25613138 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 6.54e-05 | 351 | 68 | 6 | 38297188 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 21368048 | ||
| Pubmed | Hippocampal AMPA receptor assemblies and mechanism of allosteric inhibition. | 7.86e-05 | 7 | 68 | 2 | 33981040 | |
| Pubmed | Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. | 7.86e-05 | 7 | 68 | 2 | 10407040 | |
| Pubmed | Glutamate receptors in cortical plasticity: molecular and cellular biology. | 7.86e-05 | 7 | 68 | 2 | 9016303 | |
| Pubmed | Glutamate receptors: brain function and signal transduction. | 7.86e-05 | 7 | 68 | 2 | 9651535 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 8672451 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 27076426 | ||
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 11517230 | ||
| Pubmed | Hippocampal AMPA receptor gating controlled by both TARP and cornichon proteins. | 1.05e-04 | 8 | 68 | 2 | 21172611 | |
| Pubmed | 1.05e-04 | 8 | 68 | 2 | 19144833 | ||
| Pubmed | Synaptic profiles during neurite extension, refinement and retraction in the developing cochlea. | 1.05e-04 | 8 | 68 | 2 | 23217150 | |
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 18367611 | ||
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 24292102 | ||
| Pubmed | 1.34e-04 | 9 | 68 | 2 | 34873237 | ||
| Pubmed | Expression of glutamate receptor subunit genes during development of the mouse retina. | 1.34e-04 | 9 | 68 | 2 | 9051806 | |
| Pubmed | 1.68e-04 | 10 | 68 | 2 | 1869533 | ||
| Pubmed | Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma. | 1.68e-04 | 10 | 68 | 2 | 22421440 | |
| Pubmed | 1.72e-04 | 141 | 68 | 4 | 20056178 | ||
| Pubmed | 1.74e-04 | 55 | 68 | 3 | 18448421 | ||
| Pubmed | Interaction of nuclear receptor zinc finger DNA binding domains with histone deacetylase. | 2.05e-04 | 11 | 68 | 2 | 12943985 | |
| Pubmed | Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation. | 2.05e-04 | 11 | 68 | 2 | 9802886 | |
| Pubmed | 2.45e-04 | 12 | 68 | 2 | 11891216 | ||
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 2.61e-04 | 63 | 68 | 3 | 29162697 | |
| Pubmed | 2.89e-04 | 1103 | 68 | 9 | 34189442 | ||
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 2.90e-04 | 13 | 68 | 2 | 20859245 | |
| Pubmed | 2.90e-04 | 13 | 68 | 2 | 25218043 | ||
| Pubmed | 3.09e-04 | 300 | 68 | 5 | 19086053 | ||
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | 3.32e-04 | 1124 | 68 | 9 | 21900206 | |
| Pubmed | From the Cover: Indispensability of the glutamate transporters GLAST and GLT1 to brain development. | 3.38e-04 | 14 | 68 | 2 | 16880397 | |
| Pubmed | Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. | 3.89e-04 | 15 | 68 | 2 | 19043545 | |
| Cytoband | 10q22 | 3.26e-04 | 18 | 68 | 2 | 10q22 | |
| Cytoband | 7q11.23 | 4.15e-04 | 97 | 68 | 3 | 7q11.23 | |
| Cytoband | 11q13.3 | 4.90e-04 | 22 | 68 | 2 | 11q13.3 | |
| Cytoband | 12q22 | 1.71e-03 | 41 | 68 | 2 | 12q22 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 3.46e-05 | 4 | 44 | 2 | 1200 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.56e-03 | 206 | 44 | 4 | 682 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.73e-07 | 186 | 67 | 6 | 7812ed80d2378aca9957ef22fc3c8fb7fb58434b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.14e-06 | 172 | 67 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-06 | 173 | 67 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-06 | 175 | 67 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.98e-06 | 186 | 67 | 5 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-05 | 194 | 67 | 5 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-05 | 194 | 67 | 5 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.19e-05 | 197 | 67 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-05 | 198 | 67 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 198 | 67 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.24e-05 | 199 | 67 | 5 | ca970114b5aef4518ce580897a62ac88688b2671 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.27e-05 | 200 | 67 | 5 | 0aa316b71f195ecf17ee897e307f8928a755a637 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 1.27e-05 | 200 | 67 | 5 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.27e-05 | 200 | 67 | 5 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-05 | 153 | 67 | 4 | 6dcab3d50ab50051955204dc4e4a64c1ca855bcd | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-05 | 153 | 67 | 4 | f6ef14d949107c08cb3690e26ec91e194cb43518 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.56e-05 | 154 | 67 | 4 | dd3d34f065820e706515a13619f19a5b12734c8e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.56e-05 | 154 | 67 | 4 | 4bfda1c41efbb86d829b3797d1168bf2587c3c97 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.92e-05 | 160 | 67 | 4 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 161 | 67 | 4 | a006491c991e6a134be20ad75092a91f3b7c3c91 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.07e-04 | 163 | 67 | 4 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 164 | 67 | 4 | 15d52666e5150e7c34b1f641a937fb2d5e8aaf8a | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 164 | 67 | 4 | d622f0d8d8bad48dfdf160ec63c545df192637a9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 168 | 67 | 4 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 168 | 67 | 4 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 168 | 67 | 4 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 168 | 67 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 168 | 67 | 4 | c0aef5947b1d7e2c81a7481c509feda1687fcd7f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 168 | 67 | 4 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 168 | 67 | 4 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 168 | 67 | 4 | f377ff4c066a9857ad14d245e56325ad220e22e1 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 169 | 67 | 4 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 169 | 67 | 4 | 411556e93adcbb7e4d79b02f3dc72963ec8a0759 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 169 | 67 | 4 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 169 | 67 | 4 | 39b1acfd099abb9de18c29c05c7a67709ea76775 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.22e-04 | 169 | 67 | 4 | 84b898a9fd8ced67c6a501d5cef6416f519902c4 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-04 | 170 | 67 | 4 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 171 | 67 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Differentiating_glia|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 172 | 67 | 4 | bc3ed05fdd94d5e1f19285aea867b1453292baec | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 67 | 4 | c8cfe0ac0c1ac447c626a623cc49692a0b177a1c | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-04 | 175 | 67 | 4 | 61fbd8f685d3daad46449e4c0386a38886496566 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 176 | 67 | 4 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.43e-04 | 176 | 67 | 4 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 176 | 67 | 4 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-04 | 178 | 67 | 4 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.49e-04 | 178 | 67 | 4 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 181 | 67 | 4 | 8657d35cd3dff6c89d0fde67d7e7e81e1d6c8884 | |
| ToppCell | tumor_Lung-Fibroblasts-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 1.59e-04 | 181 | 67 | 4 | 53bcab4d6df4a3255d81877ba22fb95d4492ce9f | |
| ToppCell | FLU-Healthy-0|FLU / Virus stimulation, Condition and Cluster | 1.66e-04 | 183 | 67 | 4 | 058604ddb06b3bef131183d86b83b422dae8f6cb | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.66e-04 | 183 | 67 | 4 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | FLU-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.66e-04 | 183 | 67 | 4 | 7a6f18246c39864479e114f698581f667fa9c600 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.70e-04 | 184 | 67 | 4 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.70e-04 | 184 | 67 | 4 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.73e-04 | 185 | 67 | 4 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 186 | 67 | 4 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 186 | 67 | 4 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-9|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.81e-04 | 187 | 67 | 4 | f002ff1a7cb7577f28acff008bc2aa561ac1a4bf | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.84e-04 | 188 | 67 | 4 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-04 | 188 | 67 | 4 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-04 | 189 | 67 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.92e-04 | 190 | 67 | 4 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-04 | 190 | 67 | 4 | 4b9bac17eb7ceadada932f2d4a20a5f176088d53 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Nonclassical_monocytes|Lung / Manually curated celltypes from each tissue | 1.96e-04 | 191 | 67 | 4 | a862a571625ab7238589ff201e5954f602c3bd7e | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.96e-04 | 191 | 67 | 4 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.96e-04 | 191 | 67 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.00e-04 | 192 | 67 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 2.00e-04 | 192 | 67 | 4 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 2.00e-04 | 192 | 67 | 4 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Monocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.00e-04 | 192 | 67 | 4 | 4be5c2c946337cd3e710137726358adca563f146 | |
| ToppCell | COVID-19_Moderate-CD4+_T_activated|World / disease group, cell group and cell class | 2.04e-04 | 193 | 67 | 4 | c2a2a2c14a7085690262db5c2a70e38db67dee18 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.04e-04 | 193 | 67 | 4 | 5f732598cdb6f3bd519f044a9cc553bd2e8b1052 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 193 | 67 | 4 | cb0fb21510124883e716780bea46575620c366b8 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.04e-04 | 193 | 67 | 4 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.04e-04 | 193 | 67 | 4 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.04e-04 | 193 | 67 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-04 | 193 | 67 | 4 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 193 | 67 | 4 | 0c207879f994c227dcd1322faa69ec9e3749cdaa | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 193 | 67 | 4 | 0fbbfcc803edc3cd96b35467ad5cc573af07fd67 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | 50c5fc349533281a426bc7227a8ea9eca8d11985 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.08e-04 | 194 | 67 | 4 | 1b4a17d58793e8889484fe592dce8ee1e8fe77a9 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.08e-04 | 194 | 67 | 4 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | IPF-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 2.08e-04 | 194 | 67 | 4 | da3e1d39575969a069ef43e552afe94b2f441d0b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | 16c6fcbd36d473b883fb5361caca86eb134767ab | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 2.08e-04 | 194 | 67 | 4 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | 79baee8b35b7707bbeb07c73b5e17b68bcd7bbc2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | f6e348f1f35c526cad6c349f1fdd0bd92d18aa3c | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | 1662b110f84584e75150df0ac970e7df82f26e7e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | 421344cc4b601d9745fa72d0af3124dab11d1d27 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 194 | 67 | 4 | b31d6361fa939a92a4a3dc63c209ecd3eb514e6a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.08e-04 | 194 | 67 | 4 | ce599ed0dc181aea0584e426636de5098f34ebe6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.12e-04 | 195 | 67 | 4 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 2.12e-04 | 195 | 67 | 4 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | control-Myeloid-CD16_Monocytes|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.12e-04 | 195 | 67 | 4 | f398d08a23fdfa6202f73a7aeac3ff4c997fbdfd | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.12e-04 | 195 | 67 | 4 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | mild_COVID-19_(asymptomatic)-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 2.12e-04 | 195 | 67 | 4 | eb809331557f8c40de45b1208cbc49b621930a4b | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 2.16e-04 | 196 | 67 | 4 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 2.16e-04 | 196 | 67 | 4 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 2.16e-04 | 196 | 67 | 4 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.16e-04 | 196 | 67 | 4 | 29246378ffb1010fe6858da756ae3d13df2306ba | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 2.16e-04 | 196 | 67 | 4 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| Drug | 1NaPP1 | 5.50e-06 | 12 | 68 | 3 | CID000004877 | |
| Drug | 8-chloroadenosine | 6.13e-06 | 40 | 68 | 4 | CID000147569 | |
| Drug | Progestins | 8.23e-06 | 92 | 68 | 5 | ctd:D011372 | |
| Drug | BiM4 | 2.16e-05 | 283 | 68 | 7 | CID000002399 | |
| Drug | 8-azidoadenosine | 2.39e-05 | 19 | 68 | 3 | CID000160751 | |
| Drug | Ceforanide [60925-61-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 2.57e-05 | 195 | 68 | 6 | 3309_UP | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 2.80e-05 | 198 | 68 | 6 | 4838_DN | |
| Drug | Hemicholinium bromide [312-45-8]; Up 200; 7uM; MCF7; HT_HG-U133A | 2.88e-05 | 199 | 68 | 6 | 3216_UP | |
| Drug | hydroxyl radical | 3.50e-05 | 206 | 68 | 6 | CID000157350 | |
| Drug | 8-Cl-cAMP | 4.84e-05 | 67 | 68 | 4 | CID000100299 | |
| Drug | 3-pyridazinol 1-oxide | 5.25e-05 | 4 | 68 | 2 | CID000574311 | |
| Drug | amthamine | 6.31e-05 | 26 | 68 | 3 | CID000126688 | |
| Drug | AC1L1GTT | 6.94e-05 | 233 | 68 | 6 | CID000003837 | |
| Drug | GF109203X | 7.04e-05 | 341 | 68 | 7 | CID000002396 | |
| Drug | AC1L1E5T | 7.15e-05 | 74 | 68 | 4 | CID000002653 | |
| Drug | DiC8 | 7.62e-05 | 146 | 68 | 5 | CID000001323 | |
| Drug | AC1L1YEG | 8.74e-05 | 5 | 68 | 2 | CID000063114 | |
| Drug | Chicago acid | 8.74e-05 | 5 | 68 | 2 | CID000065740 | |
| Drug | CHEBI:570577 | 8.74e-05 | 5 | 68 | 2 | CID011334126 | |
| Drug | 1-BCP | 8.74e-05 | 5 | 68 | 2 | CID000001370 | |
| Drug | irampanel | 8.74e-05 | 5 | 68 | 2 | CID003038472 | |
| Drug | beta-N-oxalylaminoalanine | 8.74e-05 | 5 | 68 | 2 | CID000107978 | |
| Drug | LY395153 | 8.74e-05 | 5 | 68 | 2 | CID000656707 | |
| Drug | 5-h PCA | 8.74e-05 | 5 | 68 | 2 | CID000129091 | |
| Disease | Anoxemia | 5.81e-05 | 33 | 67 | 3 | C0003129 | |
| Disease | Hypoxemia | 5.81e-05 | 33 | 67 | 3 | C0700292 | |
| Disease | Hypoxia | 5.81e-05 | 33 | 67 | 3 | C0242184 | |
| Disease | Anoxia | 5.81e-05 | 33 | 67 | 3 | C0003130 | |
| Disease | phospholipase A2, membrane associated measurement | 2.26e-04 | 10 | 67 | 2 | EFO_0008259 | |
| Disease | Spastic Paraplegia, Hereditary | 4.54e-04 | 14 | 67 | 2 | C0037773 | |
| Disease | Endometrioma | 5.01e-04 | 161 | 67 | 4 | C0269102 | |
| Disease | Endometriosis | 5.01e-04 | 161 | 67 | 4 | C0014175 | |
| Disease | aggressive behaviour measurement, ADHD symptom measurement | 5.05e-04 | 68 | 67 | 3 | EFO_0007826, EFO_0007860 | |
| Disease | impotence (implicated_via_orthology) | 5.23e-04 | 15 | 67 | 2 | DOID:1875 (implicated_via_orthology) | |
| Disease | central nervous system disease (implicated_via_orthology) | 5.97e-04 | 16 | 67 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Myocardial Ischemia | 7.00e-04 | 176 | 67 | 4 | C0151744 | |
| Disease | bipolar disorder (is_marker_for) | 8.47e-04 | 19 | 67 | 2 | DOID:3312 (is_marker_for) | |
| Disease | Left Ventricle Remodeling | 1.04e-03 | 21 | 67 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 1.04e-03 | 21 | 67 | 2 | C0600519 | |
| Disease | activities of daily living score measurement | 1.04e-03 | 21 | 67 | 2 | EFO_0008451 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 1.04e-03 | 21 | 67 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | aggressive behavior | 1.47e-03 | 25 | 67 | 2 | EFO_0003015 | |
| Disease | Adenoid Cystic Carcinoma | 1.55e-03 | 100 | 67 | 3 | C0010606 | |
| Disease | hypertension (biomarker_via_orthology) | 1.79e-03 | 227 | 67 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | cytotoxicity measurement, response to clozapine | 1.98e-03 | 29 | 67 | 2 | EFO_0006952, GO_0097338 | |
| Disease | Parkinson's disease (biomarker_via_orthology) | 2.12e-03 | 30 | 67 | 2 | DOID:14330 (biomarker_via_orthology) | |
| Disease | temporal lobe epilepsy (biomarker_via_orthology) | 2.26e-03 | 31 | 67 | 2 | DOID:3328 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RGAFCEAKIKTAKRL | 21 | Q4LE39 | |
| ICSNEGLIFKLKRGK | 56 | P22362 | |
| GLIFKLKRGKEACAL | 61 | P22362 | |
| DKKCILFRIKGGKQF | 616 | P35626 | |
| CIKSLIRKFTCKLFG | 26 | Q8NHU2 | |
| IRKFTCKLFGKLNII | 31 | Q8NHU2 | |
| CIGIDKFGEILKRKA | 106 | P55263 | |
| SLRFLKREAKLCGFL | 236 | A6NI56 | |
| KREAKLCGFLQKSFL | 241 | A6NI56 | |
| KARTCFVSDLKRGLK | 211 | Q9NZ32 | |
| ERKCLLLKIRGGKQF | 616 | P25098 | |
| LRKKLRLTGTKYGCG | 31 | Q06278 | |
| EGCKGFFKRSIRKNL | 131 | P13056 | |
| GCKGFFKRSVRKNLT | 136 | P49116 | |
| KKRIAKGTTVARFCG | 366 | Q96DM1 | |
| YKRLEKRGCGTKFLS | 71 | P14555 | |
| KKDIRRGIGYLKLIC | 306 | Q7Z5J8 | |
| FLEKLAFRTGKLLKG | 421 | Q13823 | |
| CKVVILGSGVRKSFK | 4201 | Q8NEZ4 | |
| GTLFGGEVCKVIKKR | 676 | P42166 | |
| NLKKKDRGVGSTLFC | 401 | A6NM62 | |
| TLQKVFGRVKFERKG | 1236 | Q8IY21 | |
| GVARVRKSKGKFAFL | 721 | P42263 | |
| GVARVRKSKGKFAFL | 711 | P48058 | |
| FDSFIKRKVISLKGC | 81 | Q8NH49 | |
| VLLILCFIKRSKGGK | 1136 | P32004 | |
| KSGRKFAGQIREKFI | 231 | Q86UY5 | |
| KGGELLDRILKQKCF | 501 | Q9UK32 | |
| FKRKVGGLGFLVKER | 21 | P29475 | |
| RRAIGFKKLAEAVKF | 731 | P29475 | |
| AKCLTGLAVGLRKKF | 341 | Q14008 | |
| GKGGFIRAKLVCKTL | 546 | Q8NFZ0 | |
| GFRRKLFKRVKCISC | 901 | A6NNT2 | |
| LVGVVSLRFKCRKSK | 141 | Q19T08 | |
| TELKFLCLGRVGKRK | 21 | Q13158 | |
| LDKIRGKFKQFCSLL | 106 | Q8WV07 | |
| LFFGCTKKIKISRRV | 151 | P59910 | |
| CVFRVSVRKELKGGK | 81 | Q5T9C2 | |
| FIREGCLHKLTKKGL | 756 | O94887 | |
| GLLLKKLKDEGCRAF | 116 | Q16828 | |
| GKGAFSVVRRCVKKT | 21 | Q13555 | |
| LLKGCKVFVGRFKNR | 161 | P0CB38 | |
| FISGREIKKRKCLFG | 316 | O43189 | |
| KLRFLCTRGDKLFFT | 1541 | Q7Z2Y5 | |
| GSCKGLRVKKDFLRT | 21 | Q13423 | |
| LGVFSKVRFCSGRKR | 46 | P61328 | |
| RGGKKAKQRLTALFC | 201 | Q17RP2 | |
| KRFEQKGFRLVGLKF | 26 | P15531 | |
| FFLGKGKRLERLVHK | 1481 | Q5K651 | |
| KCIEGGQKFARKSTR | 101 | P08567 | |
| EALIRFGGFRKRKKA | 56 | Q86UG4 | |
| RVKCVKALKGLYGNR | 61 | P0CL83 | |
| ILGNFKSKFGIKRER | 941 | P42338 | |
| KAARIQCFKGFKLLG | 3026 | Q4LDE5 | |
| ELGRGKFAVVRKCIK | 66 | Q9UEE5 | |
| IASCLRKEYAGKRKG | 1281 | O94911 | |
| FLRFKKGKRCSLVFG | 71 | Q7LFX5 | |
| CPFSRGKKCLDFRKI | 61 | Q9BQY6 | |
| KECGKAFIRRGNLKE | 526 | Q8NDQ6 | |
| KECGKTFFSLKRIRR | 171 | P52737 | |
| QDGFKLKGATKRLCL | 86 | Q5VX71 | |
| RRKKKCVRYIQGEGS | 481 | Q9NQB0 | |
| RKDQFKRLIAGCIGK | 1146 | Q9HAV4 | |
| TGRFFGGLCLDIKRK | 491 | Q9BY07 | |
| RVKCVKALKGLYGNR | 61 | P0CL84 | |
| NRAFACGKVTIKGKR | 871 | O15040 | |
| GKRFGCLCGKRFAVK | 381 | Q96C00 | |
| SDCGKGFIKKSRLIN | 291 | Q6PF04 | |
| RVKCVKALKGLYGNR | 61 | P0CL85 | |
| CRKLGGVKKSATFRS | 106 | Q96J77 | |
| LLGSYKGKKCAFRVI | 91 | O95059 | |
| RCKDYQGIKFVKRLG | 721 | Q9P2L0 | |
| RKLLLFICGSKEKYR | 3211 | Q5T4S7 |